Latest News

Stock Info

Day Range 0
Week Range -0.145

Investor Relations

Click Here to Download our Corporate Presentation


For investment enquiries please contact: Daniel Southan-Dwyer on

For media enquiries contact: Josh Stanbury on

Company Overview

Cognetivity Neurosciences Ltd. is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA) for use in medical and commercial environments. Cognetivity’s ICA uses Artificial Intelligence and machine learning techniques to help detect the earliest signs of impairment by testing the performance of large areas of the brain, potentially allowing early diagnosis of dementia. Cognetivity aims to develop the ICA through planned clinical studies to the market in North America and Europe.

Sign up for updates